KIRA HAYNIE: Open Payments
NPI 1720795651 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,104 in 96 payments from 20 companies in 2025. Trend: 2023 $1,600 · 2024 $2,244 · 2025 $2,104
Food & beverage: $2,104
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $360 |
| E.R. Squibb & Sons, L.L.C. | 17 | $291 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $241 |
| Amgen Inc. | 9 | $177 |
| Verona Pharma, Inc. | 7 | $155 |
| Edwards Lifesciences Corporation | 5 | $148 |
| Novo Nordisk Inc | 4 | $104 |
| Boston Scientific Corporation | 4 | $101 |
| PFIZER INC. | 3 | $80 |
| HEARTFLOW, INC. | 4 | $76 |
Products named: ELIQUIS, LEQVIO, Kerendia, Ohtuvayre, SAPIEN 3 Ultra RESILIA, General - Pain Management, Repatha, CAMZYOS.
Industry payments across CA — which companies pay providers there.
